Diabetes, not CEO, dominates Sanofi earnings

American depository shares of Sanofi (Euronext:SAN; NYSE:SNY) fell $4.75 to $48.07 in New York on Tuesday as the company revealed that sales in its diabetes franchise would be flat in 2015 primarily because of competitive pricing

Read the full 366 word article

How to gain access

Continue reading with a
two-week free trial.